CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach

Conclusions
The repertoire of targeted autoantigens of patients with CIDP differs in a systematic degree from those of controls. Systematic autoantigenomic approaches can help to understand the disease and to discover novel bioinformatical tools and novel autoantigen panels to improve diagnosis, treatment, prognosis, or patient stratification.

Source: Neurology Neuroimmunology and Neuroinflammation - January 6, 2021 Category: Neurology Authors: Moritz, C. P., Tholance, Y., Stoevesandt, O., Ferraud, K., Camdessanche, J.-P., Antoine, J.-C. Tags: All Immunology, Autoimmune diseases, Peripheral neuropathy, Chronic inflammatory demyelinating polyneuropathy Article Source Type: research